Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
carboplatin (paraplatin) (1 trial)
gefitinib (iressa) (1 trial)
gemcitabine (gemzar) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Lung Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (3 total)